Hepcidin and its role in iron absorption
1Weatherall Institute of Molecular Medicine, MRC Molecular Haematology Unit, John Radcliffe Hospital, Oxford, OX3 9DS, UK. kathryn.robson@molecular-medicine.oxford.ac.uk
Gut
|April 15, 2004
Summary
Maintaining proper iron balance is vital for health. Recent advances in iron metabolism genetics have identified key proteins, like hepcidin, crucial for regulating iron homeostasis and understanding related diseases.
Area of Science:
- Biochemistry
- Genetics
- Physiology
Background:
- Iron homeostasis is critical for human health, with disorders having a global impact.
- The body lacks an active iron excretion mechanism, making iron uptake regulation essential.
- Recent genetic research has significantly advanced the understanding of iron metabolism.
Purpose of the Study:
- To highlight the importance of understanding iron uptake regulation.
- To underscore the significance of recent genetic discoveries in iron metabolism.
- To introduce key proteins involved in maintaining iron balance.
Main Methods:
- Review of recent advancements in iron metabolism genetics.
- Identification and discussion of newly discovered proteins regulating iron homeostasis.
- Analysis of the role of these proteins in disease.
Main Results:
- Major progress in understanding the genetics of iron metabolism over the last decade.
- Identification of novel proteins, including hepcidin, involved in iron homeostasis.
- Established the link between genetic discoveries and understanding iron-related diseases.
Conclusions:
- Understanding proteins regulating iron uptake is key to addressing iron homeostasis disorders.
- Hepcidin is a significant protein identified in recent advances in iron metabolism.
- Continued research into iron metabolism genetics is crucial for public health.
Related Concept Videos
01:28The Early Endosome: Endocytosis of Transferrin
4.1K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.1K
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
1.4K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.4K
01:17Hepatic Drug Excretion: Enterohepatic Cycling
3.7K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.7K
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
387
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
387